Neurodevice Co SPR Therapeutics Raises Series A
Neurodevice firm SPR Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors. The funds will be used to commercialize pain therapies using SPR's proprietary peripheral nerve stimulation technology.
9 January 2013•3 mins read
